Ocular Therapeutix (OCUL) Raw Materials (2014 - 2026)
Ocular Therapeutix (OCUL) recorded quarterly Raw Materials of $287000.0 in Q1 2026, up 42.08% quarter-over-quarter from $202000.0 in Q4 2025, and up 53.48% on a YoY basis from $187000.0 in Q1 2025.
Ocular Therapeutix (OCUL) Raw Materials (2014 - 2026) Analysis & Trends
Ocular Therapeutix's Raw Materials history runs 13 years deep, the most recent figure standing at $287000.0 for Q1 2026.
- In Q1 2026, Raw Materials rose 53.48% year-over-year to $287000.0; the TTM figure through Mar 2026 stood at $287000.0 (up 53.48% YoY), while the FY2025 annual figure was $202000.0, down 5.61% from the prior year.
- Raw Materials was $287000.0 for Q1 2026 at Ocular Therapeutix, up from $202000.0 in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $341000.0 in Q2 2023 to a low of $187000.0 in Q1 2025.
- Historically, Raw Materials has averaged $269235.3 across 5 years, with a median of $287000.0 in 2026.
- The sharpest annual moves came in 2025 and 2026: Raw Materials plunged 43.16% in 2025, then jumped 53.48% in 2026.
- A 5-year view of Raw Materials shows it stood at $309000.0 in 2022, then fell by 2.27% to $302000.0 in 2023, then retreated by 29.14% to $214000.0 in 2024, then decreased by 5.61% to $202000.0 in 2025, then soared by 42.08% to $287000.0 in 2026.
- The last three Raw Materials figures came in at $287000.0 (Q1 2026), $202000.0 (Q4 2025), and $229000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 287,000.00 |
| Dec 31, 2025 | 202,000.00 |
| Sep 30, 2025 | 229,000.00 |
| Jun 30, 2025 | 219,000.00 |
| Mar 31, 2025 | 187,000.00 |
| Dec 31, 2024 | 214,000.00 |
| Sep 30, 2024 | 196,000.00 |
| Jun 30, 2024 | 267,000.00 |
| Mar 31, 2024 | 329,000.00 |
| Dec 31, 2023 | 302,000.00 |
| Sep 30, 2023 | 293,000.00 |
| Jun 30, 2023 | 341,000.00 |
| Mar 31, 2023 | 228,000.00 |
| Dec 31, 2022 | 309,000.00 |
| Sep 30, 2022 | 317,000.00 |
| Jun 30, 2022 | 325,000.00 |
| Mar 31, 2022 | 332,000.00 |
| Dec 31, 2021 | 388,000.00 |
| Sep 30, 2021 | 370,000.00 |
| Jun 30, 2021 | 347,000.00 |